Journals in Clinical immunology

Acta Tropica

ISSN: 0001-706X
5 Year impact factor: 2.4
Impact factor: 2.1

Acta Tropica is an international journal on infectious diseases that covers public health sciences, medical and veterinary entomology, and biomedical research with particular emphasis on topics relevant to human and animal health.Its scope includes the biology of pathogens and vectors, host-parasite relationships, mechanisms of pathogenicity, clinical disease and chemotherapy. We welcome contributions in basic or applied research in disciplines such as epidemiology, disease ecology, diagnostics, interventions and control, drug and insecticide resistance, mathematical modelling, public health and social sciences, climate change, parasite and vector taxonomy, biology, ecology and behaviour, host and parasite genomics, biochemistry, immunology, and vaccine testing.Contributions may be in the form of original research papers, review articles, short communications, opinion articles, or letters to the Editors.Only manuscripts of high scientific significance and innovation will be considered for publication. Criteria for rejection without review:• Out of scope.• Manuscripts of minimal international relevance, including regional reports and studies of local interest.• Case reports.• Parasite and vector control strategies at very early inconclusive laboratory stages of development. For vector control studies, field validation is required.• Field studies not replicated at least over two years. • Studies dealing with natural products (e.g., plant extracts) not characterized from a chemical point of view.• Ethical issues, including plagiarism, submission of the manuscript to multiple journals, and lack of ethical approval where needed.Important Guidelines for AcceptanceEditors and the Editorial Board of Acta Tropica provide the following guidelines to help authors prepare manuscripts of high quality that can be considered for publication. Maximize your chances of acceptance by making sure your manuscript:• Matches the scientific scope of the journal,• Follows the instructions specified in Acta Tropica guide for authors,• Presents results that significantly advance science including innovative new approaches,• Meets quality standards of presentation and literature citation,• Demonstrates potential health or biomedical impact.The above points are critical for the publication of original papers. Be aware Editors carefully evaluate initial manuscript submissions and only those meeting the above criteria will be forwarded to review. If reviewed favourably and the authors seriously address all concerns, then chances of acceptance are increased. Review and Opinion articles may be invited by the Editors in Chief or submitted by authors responding to a recognized need. Reviews are expected to carefully synthesize and discuss the literature and make recommendations to advance respective scientific fields. Reviews and Opinions submitted by authors without research experience on the topic covered by the manuscript will not be considered. Systematic reviews adhering to PRISMA guidelines and meta-analyses are welcome. For any inquiry about Reviews and Opinions please contact our Special Content Editor, Prof. John Beier.Benefits to authors We also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services .Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our Support Center

Subscriptions

Autoimmunity Reviews

ISSN: 1568-9972
5 Year impact factor: 9.3
Impact factor: 9.2

Autoimmunity Reviews will publish up-to-date, structured reviews on diverse topics in autoimmunity, written by first-class experts in the field. The articles will include demonstrative illustrations and tables and will all have a "take-home" message.Articles will principally be invited by the Editors-in-Chief upon the recommendations of the international Editorial Board, and will cover all fields of autoimmunology, bridging the gap between basic and clinical sciences. Contributions in basic sciences will include those on the pathophysiology and mechanisms of disorders as well as genomics and proteomics; clinical contributions will focus upon the diseases, novel therapies and clinical associations.Benefits to authors We also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services .Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our Support Center

Subscriptions

Biochimica et Biophysica Acta: Molecular Basis of Disease

ISSN: 0925-4439
5 Year impact factor: 5.5
Impact factor: 4.2

BBA Molecular Basis of Disease addresses the biochemistry and molecular genetics of disease processes and models of human disease.Manuscripts should emphasize the underlying molecular mechanisms of human disease pathways and provide significant advances to the understanding and/or treatment of these disorders.Studies in model organisms or systems are strongly recommended in order to validate mechanistic insights. Topics of interest include, but are not limited toAgingCancerCardiovascular diseasesCell death–related diseasesGenetic diseasesGenetic and epigenetic regulation in diseasesImmunological diseasesInflammatory diseasesMetabolic diseasesMitochondrial diseasesMuscular diseasesNeurological diseasesThe non-preferred topics for BBADIS includeNon-coding RNAsResearch on non-coding RNAs (microRNAs, lncRNAs, circRNAs, etc.) will be considered only if it provides significantly novel insights into disease mechanisms.Single Cell Line StudiesStudies involving single cell lines will be considered only if they present significantly novel findings.Computational (in Silico) StudiesPurely computational works (e.g., Mendelian randomization, molecular docking, molecular dynamics) will generally be declined unless they provide novel insights into disease mechanisms.Disease BiomarkersResearch on disease biomarkers will be considered only if it relates to the explanation of disease mechanisms.Descriptive or Correlative StudiesDescriptive or correlative studies (e.g., up/down regulation of gene products, -omics studies without follow-up experiments) will be declined unless they provide mechanistic insights.Natural Products and Traditional MedicineWork on natural products, extracts, and traditional medicine will be considered only if single biochemical components are characterized and tested.Clinical Studies and Case ReportsClinical studies or case reports without mechanistic insights are outside the scope of the journal.Hypothesis ArticlesSubmissions based solely on hypotheses will not be considered.Comparative Genomics StudiesComparative genomics studies (e.g., GWAS) will only be considered if they provide specific insights into the structural and/or functional properties of individual genes.Incremental WorkResearch that offers incremental advancements without significant novelty or impact will generally be declined.

Subscriptions

Clinica Chimica Acta

ISSN: 0009-8981
5 Year impact factor: 3.7
Impact factor: 3.2

International Journal of Clinical Chemistry and Diagnostic Laboratory Medicine The Official Journal of the International Federation of Clinical Chemistry and Laboratory Medicine (IFCC)Clinica Chimica Acta is a high-quality journal which publishes original Research Communications in the field of clinical chemistry and laboratory medicine, defined as the diagnostic application of chemistry, biochemistry, immunochemistry, biochemical aspects of hematology, toxicology, and molecular biology to the study of human disease in body fluids and cells.The objective of the journal is to publish novel information leading to a better understanding of biological mechanisms of human diseases, their prevention, diagnosis, and patient management. Reports of an applied clinical character are also welcome. Papers concerned with normal metabolic processes or with constituents of normal cells or body fluids, such as reports of experimental or clinical studies in animals, are only considered when they are clearly and directly relevant to human disease. Evaluation of commercial products have a low priority for publication, unless they are novel or represent a technological breakthrough. Studies dealing with effects of drugs and natural products and studies dealing with the redox status in various diseases are not within the journal's scope. Development and evaluation of novel analytical methodologies where applicable to diagnostic clinical chemistry and laboratory medicine, including point-of-care testing, and topics on laboratory management and informatics will also be considered. Studies focused on emerging diagnostic technologies and (big) data analysis procedures including digitalization, mobile Health, and artificial Intelligence applied to Laboratory Medicine are also of interest.

Subscriptions

Clinical Immunology

ISSN: 1521-6616
5 Year impact factor: 4.7
Impact factor: 4.5

Clinical Immunology publishes original research on the molecular and cellular bases of immunological disease. The journal also features reviews of timely topics in basic immunology, case reports, and letters to the editor.Research Areas Include:• Ageing • Allergy • Autoimmunity • Biotechnology • Clinical Laboratory Immunology • HIV • Immunodermatology • Immunohematology • Immunotoxicology/Environmental • Infection and Immunity • Mucosal Immunity • Neuroimmunology • Primary Immunodeficiency • Transplantation • Tumor Immunology • VaccinesBenefits to authors We also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services .Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our Support Center

Subscriptions

Clinical Microbiology Newsletter

ISSN: 0196-4399

Clinical Microbiology Newsletter is published bi-monthly to to provide consistent educational features and to keep pace with advances in the fast-moving field of Clinical Microbiology.Clinical Microbiology Newsletter aims to provide articles to enable you to streamline procedures and improve results. It publishes reviews on infectious disease pathogens, reports on changes that affect your work, including articles on new diagnostic techniques, regulatory and guideline changes, and challenging diagnostic dogmas, clinical cases focused on diagnostic approaches for both common and uncommon pathogens.The journal publishes three types of articles:Mini-reviews Case presentationsMicrobe SnapshotsThese articles cover topics including:Minireviews on the epidemiology, pathogenesis, clinical presentation, diagnosis, and treatment of infectious diseases,Practical articles on common and contemporary laboratory techniques,Indispensable updates on important clinical problems that impact the clinical laboratory,Editorials and opinions on controversial issues in laboratory medicine,Case-based articles focused on diagnostic approaches for infectious pathogens,Snapshots highlighting specific infectious pathogens,Helpful tips on improving the laboratory workplace.

Subscriptions

Comparative Immunology, Microbiology & Infectious Diseases

ISSN: 0147-9571
5 Year impact factor: 2.2
Impact factor: 2

An International Journal focused on Comparative Veterinary and Medical ResearchComparative Immunology, Microbiology & Infectious Diseases aims to respond to the concept of "One Medicine - One Health" and to provide a venue for scientific exchange. Based on the concept of "Comparative Medicine" interdisciplinary cooperation between specialists in human and animal medicine is of mutual interest and benefit. Therefore, there is need to combine the respective interest of physicians, veterinarians and other health professionals for comparative studies relevant to either human or animal medicine .CIMID is mainly focusing on applied veterinary medicine with a particular focus on zoonotic pathogens. It includes etiology, biology, clinical diseases, epidemiology, diagnosis, control. Experimental in vitro studies and studies on laboratory animals are generally not accepted. Non infectious diseases are not accepted. Specific focus on human diseases can only be accepted if it concerns major zoonotic pathogens. Reviews are generally not accepted, except if they contain new or recent developments. CIMID does not accept manuscript focusing on Mycology.The journal is open to subjects of common interest related to the immunology, immunopathology, microbiology, parasitology and epidemiology of human and animal infectious diseases, especially zoonotic infections, and animal models of human infectious diseases. The role of environmental factors in disease emergence is emphasized. CIMID is mainly focusing on applied veterinary and human medicine rather than on fundamental experimental research.Original research papers of high quality and novelty on aspects of host response, molecular biology, pathogenesis, control and prevention and treatment of microbial and parasitic diseases of domestic animals and wildlife (if the infections are of zoonotic interest and/or in relation with domestic animals and/or can serve as a model for human diseases). Papers dealing primarily with epidemiology will be considered if they demonstrate a clear impact on the clinical features, pathogenesis or prevention of a disease. Similarly, articles addressing microbiology, parasitology, immunology or pathogenesis must address issues of comparative medical interest. Manuscripts focusing on probiotics or diseases and/or immunology of fishes are not part of our overall scope, as they are better fitted to more specialized journals. Manuscripts dealing with food hygiene and food risk are not part of our overall scope. Manuscripts dealing strictly with experimental design and fundamental research may not be considered depending the overall consequences for the knowledge of a disease.Review articles can be accepted. They should focus either on a pathogen or on analyses of the mechanisms of host-pathogen interactions including epidemiological studies. Proposal for such manuscripts should be submitted to the Co-Editors in Chief for approval before submitting the manuscript.Papers focusing solely on diagnostic techniques, case reports or drug trials will generally not be accepted. Papers of geographically limited interest, which repeat what had been established elsewhere, will not be considered. The readership of the journal is global. The Editors reserve the right to suggest submission to another journal for those papers which they feel would be more appropriate for consideration by that journal.Papers will be rejected if standards of care of, or procedures performed on animals are not beyond those expected of humane veterinary care. Standards must, at least, meet the International Guiding Principles for Biomedical Research involving Animals, as issued by the Council for International Organizations of Medical Sciences. (C.I.O.M.S., c/o WHO, CH 1211 Geneva 27, Switzerland).Instruction for Authors:Comparative Immunology, Microbiology & Infectious Diseases consists of six issues a year and publishes original papers or reviews of the status of current research relative to the different fields of Immunology, Microbiology and Infectious Diseases of animals with a possible impact on human health.Immunology: manuscripts are accepted relative to the various branches of this discipline: fundamental Immunology, experimental or comparative Immunology, clinical Immunology, Immunopathology.Microbiology: manuscripts are accepted relative to the various branches of this discipline: Virology, Bacteriology, Parasitology.Infectious Diseases: manuscripts are accepted relative to the various branches: Etiology, Pathogenesis, Diagnosis, Prophylaxis, Treatment, Epidemiology, Epizootiology of infectious diseases of animals with a particular interest on zoonoses and one health.

Subscriptions

Diagnostic Microbiology and Infectious Disease

ISSN: 0732-8893
5 Year impact factor: 2
Impact factor: 2.1

Diagnostic Microbiology and Infectious Disease provides up to date and extensive articles on clinical microbiology.Diagnostic Microbiology and Infectious Disease aims to publish latest developments in clinical microbiology and the diagnosis and treatment of infectious diseases. It publishes articles on studies in bacteriology, immunology, immunoserology.Submissions on new procedures, unusual cases, controversial issues, and important new literature. are particularly welcomed.The journal publishes topics including:Informed commentaries on new antibioticsRapid and cost-effective methods in the laboratoryInstructive case studies with emphasis on complex circumstancesInsightful editorials on important current issuesBook reviews that keep you up-to-date on recently published literatureLaboratory and clinical management of microbial diseasesEpidemiology and pathogenesis of infectionsAutomation in the diagnostic microbiology laboratoryAntibiotic susceptibility testing

Subscriptions

European Journal of Cancer

ISSN: 0959-8049
5 Year impact factor: 7.7
Impact factor: 7.6

Official Journal of EORTC and EUSOMAThe European Journal of Cancer (EJC) integrates preclinical, digital, translational, and clinical research in cancer, from epidemiology, carcinogenesis and biology through to innovations in cancer treatment and patient care. The journal publishes original research, reviews, previews, editorial comments and correspondence.The EJC is the official journal of the European Organisation for Research and Treatment of Cancer (EORTC) and the European Society of Breast Cancer Specialists (EUSOMA).

Subscriptions

European Journal of Internal Medicine

ISSN: 0953-6205
5 Year impact factor: 5.1
Impact factor: 5.9

The Official Journal of the European Federation of Internal Medicine (EFIM)European Journal of Internal Medicine is the official journal of the European Federation of Internal Medicine and is the reference scientific journal for the European academic and non-academic internists. The journal is devoted to promoting science and practice in internal medicine in Europe. To this end, the journal publishes original articles, editorials, reviews, internal medicine flashcards, and other information relevant to internal medicine and related fields. Translational medicine and clinical studies both receive attention by the Journal. EJIM has the ambition to become the place for the publication of excellent clinical studies; however, this target is intended to be associated with the improvement of the quality of health care in Internal Medicine in the European hospitals.The journal encourages the submission, as original articles, of: quality clinical studies related to internal medicine;papers defining the unmet clinical needs in several areas of internal medicine;methodology of clinical research and critical reading of clinical studies;high-level subgroup or secondary analyses of the major clinical trials;experimental design of planned or ongoing large clinical trials. This publication may be associated with a critical assessment by methodology experts commenting the methodology of the paper, strengths and potential limitations;acute and critical care medicine as well as emergency medicine to contribute to develop the new professional figure of the internist in the European hospitals;In addition to the abovementioned articles, the journal publishes invited articles on clinical issues relevant to internal medicine, in the form of: Commentary: a paper commenting an article published in a particular issue and prepared by the Editors or by an invited expert;Editorial: a brief article on clinical achievements or debated points in Internal Medicine;Review Articles: updated state-of-the-art reviews on a subject of clinical relevance;Ideas and Opinions: a paper on a vision concerning a clinical topic not necessarily reflecting evidence-based data but more an expression of a particular vision of a clinical or public health issue;Clinical Controversies in Internal medicine, covering pros and cons positions on a specific clinical issue;Clinical Insights: a brief article dedicated to the management of particular clinical situation or setting where remarkable advancements or changes in clinical practice were recently experienced;Beyond the guidelines on clinical situations or issues that are not covered by the Guidelines or on the limitations of the Guidelines. More in general, this type of articles can be a commentary on recently published guidelines.

Subscriptions

Life Sciences

Physical Sciences & Engineering

Social Sciences & Humanities

Health

Journals in Clinical immunology

Acta Tropica

Autoimmunity Reviews

Biochimica et Biophysica Acta: Molecular Basis of Disease

Clinica Chimica Acta

Clinical Immunology

Clinical Microbiology Newsletter

Comparative Immunology, Microbiology & Infectious Diseases

Diagnostic Microbiology and Infectious Disease

European Journal of Cancer

European Journal of Internal Medicine